AstraZeneca stock heads into the open after a 1.2% slide

At the close on September 8, 2026, AstraZeneca stock finished at GBP 119.00 on the London Stock Exchange, down 1.18 percent with an intraday range between GBP 118.53 and GBP 121.16. The move came as the FTSE 100 closed 0.10 percent lower.

AstraZeneca stock closed at GBP 119.00 on the London Stock Exchange on September 8, 2026, down 1.18 percent from the previous session, with the share moving between GBP 118.53 and GBP 121.16 during the day.Investing.com Compared with the FTSE 100, which finished 0.10 percent lower at 10,811.66 points on September 8, 2026, AstraZeneca showed a clearly weaker performance.Reuters market wrap

September 8, 2026 in numbers

AstraZeneca PLC (ISIN GB0009895292, LSE: AZN) saw trading volume of about 1.53 million shares on September 8, 2026, as it slipped 1.18 percent to a GBP 119.00 close, within a session range from GBP 118.53 at the low to GBP 121.16 at the high.Investing.com Market data indicated that the stock remained within its broader 52 week range while underperforming the FTSE 100 benchmark, which closed at 10,811.66 points, down 0.10 percent on the day.Reuters market wrap Commentary on London trading highlighted pressure from higher oil prices and renewed inflation concerns across European markets, which weighed modestly on the index and on large health care names such as AstraZeneca.Reuters market wrap

Today’s agenda for AstraZeneca

According to the company’s investor relations calendar, AstraZeneca is due to present its half year and second quarter 2026 results update via an investor event scheduled for September 8, 2026 at 4 p.m. BST, giving investors fresh detail on recent performance and guidance.AstraZeneca investor relations With European equities recently reacting to moves in crude prices and inflation expectations, broader market developments in the coming session may continue to frame sentiment toward defensive health care stocks including AstraZeneca.Reuters market wrap